{"id":"https://openalex.org/W1983405941","doi":"https://doi.org/10.1007/s00280-011-1649-1","title":"Methylseleninic acid inhibits HDAC activity in diffuse large B-cell lymphoma cell lines","display_name":"Methylseleninic acid inhibits HDAC activity in diffuse large B-cell lymphoma cell lines","publication_year":2011,"publication_date":"2011-04-25","ids":{"openalex":"https://openalex.org/W1983405941","doi":"https://doi.org/10.1007/s00280-011-1649-1","mag":"1983405941","pmid":"https://pubmed.ncbi.nlm.nih.gov/21519842"},"language":"en","primary_location":{"id":"doi:10.1007/s00280-011-1649-1","doi":"https://doi.org/10.1007/s00280-011-1649-1","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00280-011-1649-1","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://hal.science/hal-00691341","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084558073","display_name":"Shireen Kassam","orcid":"https://orcid.org/0000-0002-6173-3326","observed_orcids":["https://orcid.org/0000-0002-6173-3326"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Shireen Kassam","raw_affiliation_strings":["Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. s.a.kassam@qmul.ac.uk","Queen Mary University of London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. s.a.kassam@qmul.ac.uk","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]},{"raw_affiliation_string":"Queen Mary University of London","institution_ids":["https://openalex.org/I166337079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002782784","display_name":"Heidi Goenaga Infante","orcid":"https://orcid.org/0000-0002-2416-9666","observed_orcids":["https://orcid.org/0000-0002-2416-9666"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heidi Goenaga-Infante","raw_affiliation_strings":["LGC Limited, London, UK","LGC Limited"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LGC Limited, London, UK","institution_ids":[]},{"raw_affiliation_string":"LGC Limited","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113537997","display_name":"Lenushka Maharaj","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lenushka Maharaj","raw_affiliation_strings":["Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, EC1B 6BQ, UK","Queen Mary University of London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, EC1B 6BQ, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]},{"raw_affiliation_string":"Queen Mary University of London","institution_ids":["https://openalex.org/I166337079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035288566","display_name":"Crispin T. Hiley","orcid":"https://orcid.org/0000-0002-5869-0775","observed_orcids":["https://orcid.org/0000-0002-5869-0775"]},"institutions":[{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Crispin T. Hiley","raw_affiliation_strings":["Centre for Molecular Oncology and Imaging, Barts Cancer Institute, London, UK","Centre for Molecular Oncology and Imaging, Barts Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Molecular Oncology and Imaging, Barts Cancer Institute, London, UK","institution_ids":["https://openalex.org/I4405264518"]},{"raw_affiliation_string":"Centre for Molecular Oncology and Imaging, Barts Cancer Institute","institution_ids":["https://openalex.org/I4405264518"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018281504","display_name":"Simone Jueliger","orcid":"https://orcid.org/0000-0001-5225-7236","observed_orcids":["https://orcid.org/0000-0001-5225-7236"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simone Juliger","raw_affiliation_strings":["Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, EC1B 6BQ, UK","Queen Mary University of London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, EC1B 6BQ, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]},{"raw_affiliation_string":"Queen Mary University of London","institution_ids":["https://openalex.org/I166337079"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109953232","display_name":"Simon P. Joel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Simon P. Joel","raw_affiliation_strings":["Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, EC1B 6BQ, UK","Queen Mary University of London"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, EC1B 6BQ, UK","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]},{"raw_affiliation_string":"Queen Mary University of London","institution_ids":["https://openalex.org/I166337079"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109953232"],"corresponding_institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":1.4979,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.80674343,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"68","issue":"3","first_page":"815","last_page":"821"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11931","display_name":"Organoselenium and organotellurium chemistry","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11107","display_name":"Selenium in Biological Systems","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methylseleninic-acid","display_name":"methylseleninic acid","score":1.0},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibition","display_name":"histone deacetylase inhibition","score":0.9139999747276306},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9879999756813049},{"id":"https://openalex.org/keywords/selenium-metabolites","display_name":"selenium metabolites","score":0.746999979019165},{"id":"https://openalex.org/keywords/methylselenol","display_name":"methylselenol","score":0.996999979019165},{"id":"https://openalex.org/keywords/dimethylselenide","display_name":"dimethylselenide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/histone-h3-acetylation","display_name":"histone H3 acetylation","score":0.9729999899864197},{"id":"https://openalex.org/keywords/alpha-tubulin-acetylation","display_name":"alpha-tubulin acetylation","score":0.9549999833106995},{"id":"https://openalex.org/keywords/hif-1alpha","display_name":"HIF-1\u03b1","score":0.8489999771118164},{"id":"https://openalex.org/keywords/vegf-secretion","display_name":"VEGF secretion","score":0.8989999890327454},{"id":"https://openalex.org/keywords/hypoxia","display_name":"hypoxia","score":0.9419999718666077},{"id":"https://openalex.org/keywords/organoselenium-compounds","display_name":"organoselenium compounds","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.6822589635848999},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5598160624504089},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.5554637312889099},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.5246720314025879},{"id":"https://openalex.org/C119157956","wikidata":"https://www.wikidata.org/wiki/Q796604","display_name":"Acetylation","level":3,"score":0.5048471093177795},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4736800491809845},{"id":"https://openalex.org/C2776262904","wikidata":"https://www.wikidata.org/wiki/Q905901","display_name":"Vorinostat","level":5,"score":0.4690960645675659},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4603005051612854},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.44949859380722046},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4216732382774353},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.4060613214969635},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.374796062707901},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.350569486618042},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2760258913040161},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.23503345251083374},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.061636120080947876},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D003553","descriptor_name":"Cystine","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003553","descriptor_name":"Cystine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006655","descriptor_name":"Histone Deacetylases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012643","descriptor_name":"Selenium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D016566","descriptor_name":"Organoselenium Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051795","descriptor_name":"Hypoxia-Inducible Factor 1, alpha Subunit","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1007/s00280-011-1649-1","doi":"https://doi.org/10.1007/s00280-011-1649-1","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00280-011-1649-1","pdf_url":null,"source":{"id":"https://openalex.org/S117498271","display_name":"Cancer Chemotherapy and Pharmacology","issn_l":"0344-5704","issn":["0344-5704","1432-0843"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Chemotherapy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:21519842","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21519842","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer chemotherapy and pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-00691341v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-00691341","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Chemotherapy and Pharmacology, 2011, 68 (3), pp.815-821. ⟨10.1007/s00280-011-1649-1⟩","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:tara.tcd.ie:2262/63198","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2262/63198","pdf_url":null,"source":{"id":"https://openalex.org/S4306400387","display_name":"Trinity's Access to Research Output (TARA) (Trinity College Dublin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I205274468","host_organization_name":"Trinity College Dublin","host_organization_lineage":["https://openalex.org/I205274468"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":null}],"best_oa_location":{"id":"pmh:oai:HAL:hal-00691341v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-00691341","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Chemotherapy and Pharmacology, 2011, 68 (3), pp.815-821. ⟨10.1007/s00280-011-1649-1⟩","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W1947491916","https://openalex.org/W1969461868","https://openalex.org/W1970739279","https://openalex.org/W1985307415","https://openalex.org/W2001832527","https://openalex.org/W2029207655","https://openalex.org/W2031654513","https://openalex.org/W2050931169","https://openalex.org/W2053216713","https://openalex.org/W2057561198","https://openalex.org/W2067670440","https://openalex.org/W2072093490","https://openalex.org/W2080115164","https://openalex.org/W2101911974","https://openalex.org/W2102056087","https://openalex.org/W2103102045","https://openalex.org/W2108165389","https://openalex.org/W2112392983","https://openalex.org/W2114042577","https://openalex.org/W2138818608","https://openalex.org/W2142233318","https://openalex.org/W2146252974","https://openalex.org/W2154455873","https://openalex.org/W2159797128","https://openalex.org/W2162542545","https://openalex.org/W2169727811","https://openalex.org/W2373906990","https://openalex.org/W4253116009"],"related_works":["https://openalex.org/W2325529549","https://openalex.org/W1590941842","https://openalex.org/W2294043069","https://openalex.org/W2138818608","https://openalex.org/W2114042577","https://openalex.org/W2982017837","https://openalex.org/W2108165389","https://openalex.org/W2585170510","https://openalex.org/W2791683818","https://openalex.org/W1971738816"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}